Ajay Khopade
Vice President, Head of Formulation Non-Orals & Analytical, & R&D Site Head Sun Pharmaceutical Industries
Seminars
Thursday 21st January 2027
Lifecycle Extension Through Ophthalmic Drug Delivery Innovation via Reformulation & Repurposing of drug molecules
3:00 pm
- Development of a novel swollen micelle microemulsion (SMM) technology to enhance solubility and room-temperature stability of latanoprost
- Elimination of high benzalkonium chloride (BAK) dependency, reducing potential ocular surface safety concerns associated with chronic therapy
- Improved patient convenience through removal of cold-chain storage requirements and enhanced formulation tolerability.
- Successful progression from formulation concept through clinical development, regulatory approval, and commercialization, illustrating the value of drug delivery-driven lifecycle management
